v3.26.3
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
(in thousands, except per share data)Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Numerator
Net increase (decrease) in net assets resulting from operations$93,568 $119,685 $266,251 $248,909 
Less: Total distributions declared(87,969)(85,388)(262,652)(249,855)
Total Earnings (loss), net of total distributions5,599 34,297 3,599 (946)
Earnings (loss), net of distributions attributable to common shares5,555 34,042 3,568 (947)
Add: Distributions declared attributable to common shares87,267 84,752 260,320 247,749 
Numerator for basic change in net assets per common share92,822 118,794 263,888 246,802 
Add: Income impact of assumed conversion of 2028 Convertible Notes4,0794,11612,236 9,096
Numerator for diluted change in net assets per common share$96,901 $122,910 $276,124 $255,898 
Denominator
Basic weighted average common shares outstanding185,989180,360184,767175,633
Incremental shares from assumed conversion of 2028 Convertible Notes13,38713,38713,38710,015
Common shares issuable702611683603
Weighted average common shares outstanding assuming dilution200,078194,358198,837186,251
Change in net assets per common share:
Basic$0.50 $0.66 $1.43 $1.41 
Diluted$0.48 $0.63 $1.39 $1.37 
Schedule of Number of Anti-diluted Shares as Calculated Based on Weighted Average Closing Price of Common Stock
The calculation of change in net assets resulting from operations per common share assuming dilution, excludes all anti-dilutive shares. For the three and nine months ended September 30, 2026 and 2025, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
Anti-dilutive Securities2026202520262025
Unvested common stock options451,5271601,217
Unvested restricted stock awards33,068—91,3541,094